Comparison of two enteric coated microsphere preparations in the treatment of pancreatic exocrine insufficiency caused by cystic fibrosis

B. Santini, M. Antonelli, A. Battistini, S. Bertasi, M. Collura, I. Esposito, L. Di Febbraro, R. Ferrari, L. Ferrero, L. Iapichino, V. Lucidi, A. Manca, C. L. Pisconti, G. Pisi, V. Raia, L. Romano, P. Rosati, I. Grazioli, G. Melzi

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Background. Pancreatic exocrine insufficiency is a common condition in patients with cystic fibrosis. Large amounts of pancreatic enzyme supplements are required to reduce malabsorption but patient compliance is not always optimal. Aims. To compare patients' preference and the efficacy of two enteric coated microsphere preparations in patients with cystic fibrosis. Patients. Patients with pancreatic exocrine insufficiency due to cystic fibrosis. Methods. Patients were assigned to the crossover treatment with Creon® or Pancrease® for 1 week and then to the alternative treatment. Patients had to follow a fixed diet [at least 2 g fat/kg] and had to assume 1000 units lipase/g fat. The evaluation parameters were: patients' preference, acceptance of therapy, stool fat excretion, stool weight, gastrointestinal symptoms, and tolerance. Results and conclusions. Of the 33/60 patients who expressed a preference for one of the two treatments, 30 preferred Creon® while only 3 patients preferred Pancrease® [p

Original languageEnglish
Pages (from-to)406-411
Number of pages6
JournalDigestive and Liver Disease
Volume32
Issue number5
Publication statusPublished - 2000

Fingerprint

Exocrine Pancreatic Insufficiency
Microspheres
Cystic Fibrosis
Pancrelipase
Patient Preference
Fats
Therapeutics
Patient Compliance
Lipase
Diet
Weights and Measures

Keywords

  • Cystic fibrosis
  • Malabsorption
  • Pancreatic exocrine insufficiency
  • Pancreatic extracts

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Santini, B., Antonelli, M., Battistini, A., Bertasi, S., Collura, M., Esposito, I., ... Melzi, G. (2000). Comparison of two enteric coated microsphere preparations in the treatment of pancreatic exocrine insufficiency caused by cystic fibrosis. Digestive and Liver Disease, 32(5), 406-411.

Comparison of two enteric coated microsphere preparations in the treatment of pancreatic exocrine insufficiency caused by cystic fibrosis. / Santini, B.; Antonelli, M.; Battistini, A.; Bertasi, S.; Collura, M.; Esposito, I.; Di Febbraro, L.; Ferrari, R.; Ferrero, L.; Iapichino, L.; Lucidi, V.; Manca, A.; Pisconti, C. L.; Pisi, G.; Raia, V.; Romano, L.; Rosati, P.; Grazioli, I.; Melzi, G.

In: Digestive and Liver Disease, Vol. 32, No. 5, 2000, p. 406-411.

Research output: Contribution to journalArticle

Santini, B, Antonelli, M, Battistini, A, Bertasi, S, Collura, M, Esposito, I, Di Febbraro, L, Ferrari, R, Ferrero, L, Iapichino, L, Lucidi, V, Manca, A, Pisconti, CL, Pisi, G, Raia, V, Romano, L, Rosati, P, Grazioli, I & Melzi, G 2000, 'Comparison of two enteric coated microsphere preparations in the treatment of pancreatic exocrine insufficiency caused by cystic fibrosis', Digestive and Liver Disease, vol. 32, no. 5, pp. 406-411.
Santini, B. ; Antonelli, M. ; Battistini, A. ; Bertasi, S. ; Collura, M. ; Esposito, I. ; Di Febbraro, L. ; Ferrari, R. ; Ferrero, L. ; Iapichino, L. ; Lucidi, V. ; Manca, A. ; Pisconti, C. L. ; Pisi, G. ; Raia, V. ; Romano, L. ; Rosati, P. ; Grazioli, I. ; Melzi, G. / Comparison of two enteric coated microsphere preparations in the treatment of pancreatic exocrine insufficiency caused by cystic fibrosis. In: Digestive and Liver Disease. 2000 ; Vol. 32, No. 5. pp. 406-411.
@article{1fa3ca88d3874a159fecd5d98eb7cddf,
title = "Comparison of two enteric coated microsphere preparations in the treatment of pancreatic exocrine insufficiency caused by cystic fibrosis",
abstract = "Background. Pancreatic exocrine insufficiency is a common condition in patients with cystic fibrosis. Large amounts of pancreatic enzyme supplements are required to reduce malabsorption but patient compliance is not always optimal. Aims. To compare patients' preference and the efficacy of two enteric coated microsphere preparations in patients with cystic fibrosis. Patients. Patients with pancreatic exocrine insufficiency due to cystic fibrosis. Methods. Patients were assigned to the crossover treatment with Creon{\circledR} or Pancrease{\circledR} for 1 week and then to the alternative treatment. Patients had to follow a fixed diet [at least 2 g fat/kg] and had to assume 1000 units lipase/g fat. The evaluation parameters were: patients' preference, acceptance of therapy, stool fat excretion, stool weight, gastrointestinal symptoms, and tolerance. Results and conclusions. Of the 33/60 patients who expressed a preference for one of the two treatments, 30 preferred Creon{\circledR} while only 3 patients preferred Pancrease{\circledR} [p",
keywords = "Cystic fibrosis, Malabsorption, Pancreatic exocrine insufficiency, Pancreatic extracts",
author = "B. Santini and M. Antonelli and A. Battistini and S. Bertasi and M. Collura and I. Esposito and {Di Febbraro}, L. and R. Ferrari and L. Ferrero and L. Iapichino and V. Lucidi and A. Manca and Pisconti, {C. L.} and G. Pisi and V. Raia and L. Romano and P. Rosati and I. Grazioli and G. Melzi",
year = "2000",
language = "English",
volume = "32",
pages = "406--411",
journal = "Digestive and Liver Disease",
issn = "1590-8658",
publisher = "Elsevier B.V.",
number = "5",

}

TY - JOUR

T1 - Comparison of two enteric coated microsphere preparations in the treatment of pancreatic exocrine insufficiency caused by cystic fibrosis

AU - Santini, B.

AU - Antonelli, M.

AU - Battistini, A.

AU - Bertasi, S.

AU - Collura, M.

AU - Esposito, I.

AU - Di Febbraro, L.

AU - Ferrari, R.

AU - Ferrero, L.

AU - Iapichino, L.

AU - Lucidi, V.

AU - Manca, A.

AU - Pisconti, C. L.

AU - Pisi, G.

AU - Raia, V.

AU - Romano, L.

AU - Rosati, P.

AU - Grazioli, I.

AU - Melzi, G.

PY - 2000

Y1 - 2000

N2 - Background. Pancreatic exocrine insufficiency is a common condition in patients with cystic fibrosis. Large amounts of pancreatic enzyme supplements are required to reduce malabsorption but patient compliance is not always optimal. Aims. To compare patients' preference and the efficacy of two enteric coated microsphere preparations in patients with cystic fibrosis. Patients. Patients with pancreatic exocrine insufficiency due to cystic fibrosis. Methods. Patients were assigned to the crossover treatment with Creon® or Pancrease® for 1 week and then to the alternative treatment. Patients had to follow a fixed diet [at least 2 g fat/kg] and had to assume 1000 units lipase/g fat. The evaluation parameters were: patients' preference, acceptance of therapy, stool fat excretion, stool weight, gastrointestinal symptoms, and tolerance. Results and conclusions. Of the 33/60 patients who expressed a preference for one of the two treatments, 30 preferred Creon® while only 3 patients preferred Pancrease® [p

AB - Background. Pancreatic exocrine insufficiency is a common condition in patients with cystic fibrosis. Large amounts of pancreatic enzyme supplements are required to reduce malabsorption but patient compliance is not always optimal. Aims. To compare patients' preference and the efficacy of two enteric coated microsphere preparations in patients with cystic fibrosis. Patients. Patients with pancreatic exocrine insufficiency due to cystic fibrosis. Methods. Patients were assigned to the crossover treatment with Creon® or Pancrease® for 1 week and then to the alternative treatment. Patients had to follow a fixed diet [at least 2 g fat/kg] and had to assume 1000 units lipase/g fat. The evaluation parameters were: patients' preference, acceptance of therapy, stool fat excretion, stool weight, gastrointestinal symptoms, and tolerance. Results and conclusions. Of the 33/60 patients who expressed a preference for one of the two treatments, 30 preferred Creon® while only 3 patients preferred Pancrease® [p

KW - Cystic fibrosis

KW - Malabsorption

KW - Pancreatic exocrine insufficiency

KW - Pancreatic extracts

UR - http://www.scopus.com/inward/record.url?scp=0033868481&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033868481&partnerID=8YFLogxK

M3 - Article

VL - 32

SP - 406

EP - 411

JO - Digestive and Liver Disease

JF - Digestive and Liver Disease

SN - 1590-8658

IS - 5

ER -